[go: up one dir, main page]

NO992870D0 - Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem - Google Patents

Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem

Info

Publication number
NO992870D0
NO992870D0 NO992870A NO992870A NO992870D0 NO 992870 D0 NO992870 D0 NO 992870D0 NO 992870 A NO992870 A NO 992870A NO 992870 A NO992870 A NO 992870A NO 992870 D0 NO992870 D0 NO 992870D0
Authority
NO
Norway
Prior art keywords
pct
preparation
tetrahydropyridines
diphenylalkyl
processes
Prior art date
Application number
NO992870A
Other languages
English (en)
Other versions
NO313282B1 (no
NO992870L (no
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO992870D0 publication Critical patent/NO992870D0/no
Publication of NO992870L publication Critical patent/NO992870L/no
Publication of NO313282B1 publication Critical patent/NO313282B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19992870A 1996-12-13 1999-06-11 Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem NO313282B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines
PCT/FR1997/002289 WO1998025904A1 (fr) 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines, procede pour leur preparation et composition pharmaceutique les contenant

Publications (3)

Publication Number Publication Date
NO992870D0 true NO992870D0 (no) 1999-06-11
NO992870L NO992870L (no) 1999-08-11
NO313282B1 NO313282B1 (no) 2002-09-09

Family

ID=9498642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992870A NO313282B1 (no) 1996-12-13 1999-06-11 Difenylalkyl-tetrahydropyridiner, fremgangsmåter for deres fremstilling og farmasöytiske blandinger inneholdende dem

Country Status (31)

Country Link
US (1) US6124318A (no)
EP (1) EP0950049B1 (no)
JP (1) JP2001505903A (no)
KR (1) KR100549656B1 (no)
CN (1) CN1144784C (no)
AT (1) ATE207056T1 (no)
AU (1) AU730142B2 (no)
BR (1) BR9713926A (no)
CA (1) CA2274946C (no)
CY (1) CY2282B1 (no)
CZ (1) CZ290242B6 (no)
DE (1) DE69707504T2 (no)
DK (1) DK0950049T3 (no)
EE (1) EE03764B1 (no)
ES (1) ES2167805T3 (no)
FR (1) FR2757161B1 (no)
HK (1) HK1024001A1 (no)
HU (1) HUP0001437A3 (no)
IL (2) IL130001A0 (no)
IS (1) IS2001B (no)
NO (1) NO313282B1 (no)
NZ (1) NZ336032A (no)
PL (1) PL192926B1 (no)
PT (1) PT950049E (no)
RS (1) RS49672B (no)
RU (1) RU2198874C2 (no)
SI (1) SI0950049T1 (no)
SK (1) SK283332B6 (no)
TR (1) TR199901290T2 (no)
UA (1) UA52708C2 (no)
WO (1) WO1998025904A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
EP1328261A2 (en) * 2000-04-12 2003-07-23 Minerva Biotechnologies Corporation Treatment of neurodegenerative disease
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
CA2551946A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galantamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
NO313282B1 (no) 2002-09-09
CZ290242B6 (cs) 2002-06-12
KR100549656B1 (ko) 2006-02-08
EE03764B1 (et) 2002-06-17
HK1024001A1 (en) 2000-09-29
YU26399A (sh) 2000-03-21
KR20000069421A (ko) 2000-11-25
BR9713926A (pt) 2000-03-21
JP2001505903A (ja) 2001-05-08
IS5074A (is) 1999-06-10
EP0950049B1 (fr) 2001-10-17
DK0950049T3 (da) 2002-01-28
ES2167805T3 (es) 2002-05-16
RU2198874C2 (ru) 2003-02-20
SK78799A3 (en) 1999-12-10
DE69707504D1 (de) 2001-11-22
FR2757161A1 (fr) 1998-06-19
US6124318A (en) 2000-09-26
CN1240428A (zh) 2000-01-05
DE69707504T2 (de) 2002-06-27
RS49672B (sr) 2007-11-15
HUP0001437A2 (hu) 2000-09-28
NO992870L (no) 1999-08-11
TR199901290T2 (xx) 1999-08-23
AU5489598A (en) 1998-07-03
IL130001A0 (en) 2000-02-29
FR2757161B1 (fr) 1999-03-12
PL192926B1 (pl) 2006-12-29
AU730142B2 (en) 2001-03-01
SK283332B6 (sk) 2003-06-03
ATE207056T1 (de) 2001-11-15
UA52708C2 (uk) 2003-01-15
PL334073A1 (en) 2000-01-31
EE9900238A (et) 1999-12-15
HUP0001437A3 (en) 2001-12-28
SI0950049T1 (en) 2002-10-31
CA2274946A1 (en) 1998-06-18
CZ211099A3 (cs) 1999-09-15
EP0950049A1 (fr) 1999-10-20
CA2274946C (en) 2005-09-20
WO1998025904A1 (fr) 1998-06-18
IS2001B (is) 2005-04-15
CY2282B1 (en) 2003-07-04
NZ336032A (en) 2000-12-22
IL130001A (en) 2006-04-10
PT950049E (pt) 2002-03-28
CN1144784C (zh) 2004-04-07

Similar Documents

Publication Publication Date Title
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
NO982330D0 (no) Pyrazolderivater, fremgangsmÕte for fremstilling derav og farmas÷ytiske preparater inneholdende nevnte derivater
DK0946546T3 (da) Pyridin-2-yl-methylaminderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som lægemidler
NO992878D0 (no) Indolin-2-on-derivater, fremgangsmÕte for fremstilling av dem og farmas°ytiske blandinger som inneholder dem
ATE250590T1 (de) Neuartiger p2x 7 rezeptor-antagonisten zur verwendung in der behandlung von entzündlichen, immuninduzierten erkrankungen oder erkrankungen des herz-kreislauf-systems
DK0564350T3 (da) 3, 5-di-tert-butyl-4-hydroxyflavoner, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger med antioxidant- og anti-vasokonstriktorisk virkning
NO973857D0 (no) 1-aryl-2-acylamino-etanforbindelser og deres anvnedelse som neurokinin-, spesielt neurokinin-1-antagonister
DK0784611T3 (da) N- (ortho-substitueret benzyloxy) - iminderivater og deres anvendelse som fungicider, acaricider eller insekticider
NO992870D0 (no) Difenylalkyl-tetrahydropyridiner, fremgangsmÕter for deres fremstilling og farmas°ytiske blandinger inneholdende dem
ES2124413T3 (es) Derivados de piridazinona con actividad farmaceutica.
MY159418A (en) New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use
NO20050764L (no) Forbindelser
TH78128A (th) สารประกอบชนิดใหม่